계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Iprocom
company
About
Iprocom focuses on the research and development of vitro diagnostic reagents and instruments.
Highlights
Details
- Last Funding Type
- Private Equity（PE）
- Industries
- Biotechnology,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2012
- Operating Status
- Active
Iprocom focuses on the research and development of vitro diagnostic reagents and instruments. Iprocom's products are deployed in the fields of biochemistry, chemiluminescence, and POCT, providing overall diagnostic solutions for clinical diagnosis.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Iprocom has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Aug 7, 2017 from a Private Equity（PE） round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 7, 2017 | Private Equity（PE） | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Iprocom is funded by 1 investors.
Asia View Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Asia View Capital
|
— | Private Equity（PE） |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
